PanGenomic Health Inc on Wednesday said its net loss widened last year with rising expenses in several areas, but its chair said he was very pleased with its progress so far.
PanGenomic is based in. | May 3, 2023
Mydecine Reports Financial Results for the Year Ended December 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DENVER, March 31, 2023 (GLOBE NEWSWIRE) Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology.
DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.